Thalidomide remains one of the most controversial yet clinically indispensable pharmaceutical compounds in modern medicine. From its tragic history as a teratogen to its current role as a cornerstone therapy for multiple myeloma and erythema nodosum leprosum (ENL), the drug has carved out a permanent niche in global healthcare. For pharmaceutical manufacturers, API importers, and procurement specialists, understanding the thalidomide buyers list and the broader supply chain is critical for navigating this highly regulated market. This guide provides a detailed overview of global thalidomide buyers, suppliers, regulatory frameworks, and procurement opportunities. The Regulatory Landscape Governing Thalidomide Trade Before engaging with any thalidomide buyer or supplier, it is essential to understand…